Vol. 1 No. 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005

Published: 2009-05-29

Articles

Pathogenetic mechanisms in B-cell lymphomagenesis

Davide Rossi, Daniela Capello, Gianluca Gaidano

https://doi.org/10.4081/hmr.v1i5.243

185

PDF: 966
- PDF
Epstein-Barr virus associated lymphomas

Eva Klein

https://doi.org/10.4081/hmr.v1i5.244

164

Untitled (): 0

PDF: 239
- PDF
Immunosuppression and lymphomagenesis

Amy Chadburn

https://doi.org/10.4081/hmr.v1i5.245

137

Untitled (): 0

PDF: 108
- PDF
The role of Epstein-Barr virus infection in human malignancies

Lawrence S. Young

https://doi.org/10.4081/hmr.v1i5.246

164

PDF: 354
- PDF
Alteration of B cell function by Epstein-Barr virus

Ralf Küppers

https://doi.org/10.4081/hmr.v1i5.247

435

PDF: 452
- PDF
Pathology of Epstein-Barr virus-related lymphomas in HIV

Luigi Maria Larocca

https://doi.org/10.4081/hmr.v1i5.248

648

PDF: 701
- PDF
Molecular pathology of post-transplant lymphoproliferative disorders

Daniela Capello, Michaela Cerri, Davide Rossi, Eva Berra, Clara Deambrogi, Silvia Franceschetti, Chiara Vendramin, Lorenzo De Paoli, Valeria Primon, Cecilia Rus, Tamara Destro, Annarita Conconi, Gianluca Gaidano

https://doi.org/10.4081/hmr.v1i5.249

486

Untitled (): 0

PDF: 300
- PDF
Treatment of Epstein-Barr virus-associated lymphomas: the role of Epstein-Barr virus-specific cytotoxic T cells

Helen E Heslop, Catherine Bollard, Stephen Gottschalk, Barbara Savoldo, Malcolm K Brenne, Cliona M Rooney

https://doi.org/10.4081/hmr.v1i5.250

133

Untitled (): 0

PDF: 261
- PDF
Treatment of ebv-associated lymphomas in hiv

Andrea Antinori, Lucia Fratino

https://doi.org/10.4081/hmr.v1i5.252

243

Untitled (): 0

PDF: 199
- PDF
New drugs and new types immunosuppression

Robin Foà

https://doi.org/10.4081/hmr.v1i5.253

139

PDF: 107
- PDF
New diagnostic tools

Maurizio Sanguinetti

https://doi.org/10.4081/hmr.v1i5.254

190

PDF: 298

Untitled (): 0
- PDF
Opportunistic infections in HIV-related lymphoma

Antonella Cingolani

https://doi.org/10.4081/hmr.v1i5.255

133

PDF: 474
- PDF
The use of purine analogues and infections

Annamaria Nosari

https://doi.org/10.4081/hmr.v1i5.256

127

Untitled (): 0

PDF: 710
- PDF
Monoclonal antibodies. How do they change the pattern of infections in lymphoproliferative diseases?

B.E. de Pauw

https://doi.org/10.4081/hmr.v1i5.257

148

Untitled (): 0

PDF: 104
- PDF
Diagnosis of hhv8 infection

Paola Cattani

https://doi.org/10.4081/hmr.v1i5.258

223

Untitled (): 0

PDF: 1531
- PDF
Kshv/hhv8-associated lymphomas

Antonino Carbone

https://doi.org/10.4081/hmr.v1i5.259

161

PDF: 230
- PDF
Hhv-8 infection and post-transplant malignancies

Mario Luppi

https://doi.org/10.4081/hmr.v1i5.260

138

Untitled (): 0

PDF: 240
- PDF
Alteration of B cell function by hepatitis C virus

Shoshana Levy

https://doi.org/10.4081/hmr.v1i5.261

265

PDF: 376
- PDF
Epidemiology of hepatitis C virus in lymphomas

Alfonso Mele

https://doi.org/10.4081/hmr.v1i5.262

151

PDF: 257
- PDF
Pathology of Helicobacter pylori-associated lymphomas

Axel Greiner

https://doi.org/10.4081/hmr.v1i5.263

205

PDF: 92
- PDF
Treatment of Helicobacter pylori-associated lymphomas

Emanuele Zucca

https://doi.org/10.4081/hmr.v1i5.264

141

Untitled (): 0

PDF: 194
- PDF
Immunoproliferative small intestinal disease associated with Campylobacter jejuni

Marc Lecuit

https://doi.org/10.4081/hmr.v1i5.265

313

PDF: 1222
- PDF
Chlamydia psittaci and ocular adnexal lymphomas

Riccardo Dolcetti

https://doi.org/10.4081/hmr.v1i5.266

248

Untitled (): 0

PDF: 263
- PDF